Literature DB >> 26980029

Prevalence and distribution of 15 high-risk human papillomavirus types in squamous cell carcinoma of the scrotum.

Andres Matoso1, Valeria Fabre2, M Ruhul Quddus3, Marcos Lepe4, Kara A Lombardo4, Pradip Manna5, Jonathan I Epstein6.   

Abstract

Which subtype(s) of high-risk human papillomavirus (hrHPV) are involved in squamous cell carcinoma (SCC) of the scrotum is unknown. Twenty-seven cases of SCC of the scrotum were retrieved, and all 15 subtypes of hrHPV and their viral loads were assessed using multiplex real-time polymerase chain reaction. The results were correlated with the histopathologic features, p16 expression, and in situ hybridization for hrHPV. hrHPV was identified in 18 (67%) of 27 of the cases, including HPV16 (n=8), HPV35 (n=7), HPV31 (n=5), HPV59 (n=5), HPV33 (n=3), HPV18 (n=2), HPV51 (n=2), HPV39 (n=1), HPV56 (n=1), and HPV82 (n=1). Of the 18 cases, 10 (56%) were infected by multiple hrHPV subtypes. In situ carcinomas had higher viral loads than invasive (50M versus 2M in average). The average age of HPV-positive and -negative cases was similar, 55 and 51, respectively. Of 11 cases of invasive carcinoma, 5 (45%) were positive for hrHPV versus 13 of 16 (81%) of in situ carcinomas. The highest proportion of hrHPV-positive cases was seen in basaloid type (7/7; 100%) and warty type (4/4; 100%), followed by usual type (7/16; 44%). Of 18 of the HPV-positive cases, 9 (50%) were also positive for p16 by immunohistochemistry and 6 of 18 (33%) were positive by in situ hybridization. Similar to SCC of the vulva and penis, the most frequently HPV-positive tumors are basaloid and warty types. However, a proportion of SCC usual type are also positive for hrHPV. Our results show that 8 (44%) of 18 of cases are associated with hrHPV subtypes other than 16 and 18. Additionally, 7 (70%) of 10 of hrHPV16/18-positive cases are coinfected with other subtypes.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HPV; Scrotum; Squamous cell carcinoma; Vaccine; p16

Mesh:

Substances:

Year:  2016        PMID: 26980029     DOI: 10.1016/j.humpath.2016.02.013

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Poorly Differentiated Scrotal Carcinoma With Apocrine Immunophenotype.

Authors:  Sonia Kamanda; Jonathan I Epstein; Adeboye O Osunkoya; Ashley Cimino-Mathews; Pedram Argani; Martin Sangüeza; Jose Antonio Plaza; Andres Matoso
Journal:  Am J Dermatopathol       Date:  2022-04-01       Impact factor: 1.533

2.  Human papillomavirus 16 is an aetiological factor of scrotal cancer.

Authors:  Núria Guimerà; Laia Alemany; Gordana Halec; Michael Pawlita; Gerard Vincent Wain; José Santos Salas Vailén; Jerome E Azike; David Jenkins; Silvia de Sanjosé; Wim Quint; F Xavier Bosch
Journal:  Br J Cancer       Date:  2017-04-04       Impact factor: 7.640

3.  Successful Treatment of Generalized Eruptive Keratoacanthoma of Grzybowski with Acitretin.

Authors:  Hélène Mascitti; Adèle De Masson; Florence Brunet-Possenti; Jean-David Bouaziz; Pauline Laly; Nadim Mourad; Jean-Michel Garrigues; Sara Laurent-Roussel; Bénédicte Cavelier-Balloy; Isabelle Moulonguet; Cristina Leschi; Samia Mourah; Martine Bagot; Céleste Lebbé; Nicole Basset-Seguin
Journal:  Dermatol Ther (Heidelb)       Date:  2019-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.